Oncologic Outcomes for Squamous Cell Carcinoma In Situ With a Clinically Resolved Biopsy Site Managed by Watchful Waiting
View abstract on PubMed
Summary
This summary is machine-generated.Watchful waiting for squamous cell carcinoma in situ (SCCIS) shows a 4% local recurrence rate. Solid-organ transplant recipients and specific tumor locations/biopsy features increase recurrence risk.
Area Of Science
- Dermatology
- Oncology
- Surgical Pathology
Background
- Treatment decisions for low-risk squamous cell carcinoma in situ (SCCIS) lack management-specific outcomes data.
- SCCIS management often involves active treatment, but non-invasive approaches require further investigation.
Purpose Of The Study
- To evaluate tumor outcomes for SCCIS managed with watchful waiting.
- To identify risk factors associated with poor outcomes in SCCIS patients managed non-operatively.
Main Methods
- Retrospective cohort study of adult SCCIS patients diagnosed between 2014-2016 at a single academic hospital.
- Analysis of local recurrence (LR), nodal metastases (NM), distant metastases (DM), and disease-specific death (DSD).
- Multivariate analysis to determine hazard ratios (HRs) for identified risk factors.
Main Results
- Of 411 SCCIS tumors managed with watchful waiting, 17 (4%) experienced local recurrence; no NM, DM, or DSD were observed.
- Solid-organ transplant recipient status was the strongest predictor of LR (HR, 9.979).
- Additional LR risk factors included tumor location on the vermilion lip or ear (HR, 9.744), head and neck (HR, 6.687), and deep biopsy margins (HR, 6.562).
Conclusions
- Watchful waiting is a viable management strategy for SCCIS with a clinically resolved biopsy site, yielding a 4% local recurrence rate.
- Identifying high-risk patients (e.g., transplant recipients, specific tumor locations) is crucial for tailoring SCCIS management.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

